CLINICAL_TRIALS
trial_result
· 2021-05-17
Clinical Trial Update: A Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of KA34 in Subjects With Knee Osteoarthritis [Phase 1]
Summary
Phase 1 trial evaluating KA34 in knee osteoarthritis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Calibr, a division of Scripps Research | Conditions: Osteoarthritis, Knee | Phase 1 | Status: COMPLETED | Results posted: 2021-05-17